CoChat

Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research

Panepinto, Julie A., Walters, Mark C., Carreras, Jeanette, Marsh, Judith, Bredeson, Christopher N., Gale, Robert Peter, Hale, Gregory A., Horan, John, Hows, Jill M., Klein, John P., Pasquini, Ricardo, Roberts, Irene, Sullivan, Keith, Eapen, Mary, Ferster, Alina, On behalf of the Non‐Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research · 2007 · British Journal of Haematology
Cited by 179

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: We report outcomes after myeloablative haematopoietic cell transplantation (HCT) from human leucocyte antigen (HLA)‐matched sibling donors in 67 patients with sickle cell disease transplanted between 1989 and 2002. The most common indications for transplantation were stroke and recurrent vaso‐occlusive crisis in 38% and 37% of patients respectively. The median age at transplantation was 10 years and 67% of patients had received >10 red blood cell transfusions before HCT. Twenty‐seven percent of patients had a poor performance score at transplantation. Ninety‐four percent received busulfan and cyclophosphamide‐containing conditioning regimens and bone marrow was the predominant source of donor cells. Most patients achieved haematopoietic recovery and no deaths occurred during the early post‐transplant period. Rates of acute and chronic graft‐versus‐host disease were 10% and 22% respectively. Sixty‐four of 67 patients are alive with 5‐year probabilities of disease‐free and overall survival of 85% and 97% respectively. Nine patients had graft failure with recovery of sickle erythropoiesis, eight of who had recurrent sickle‐related events. This report confirms and extends earlier reports that HCT from HLA‐matched related donors offers a very high survival rate, with few transplant‐related complications and the elimination of sickle‐related complications in the majority of patients who undergo this therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2007.06592.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 179

Metadata

Authors
Panepinto, J. A., Walters, M. C., Carreras, J., Marsh, J., Bredeson, C. N., Gale, R. P., Hale, G. A., Horan, J., Hows, J. M., Klein, J. P., Pasquini, R., Roberts, I., Sullivan, K., Eapen, M., Ferster, A., & On behalf of the Non‐Malignant Marrow Disorders Working Committee, C. F. I. B. A. M. T. R.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2007-05
Volume
137
Issue
5
Pages
479-485
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2009398387
Cited by
179
References
6
FWCI
6.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. https://app.cochat.ai/papers/10.1111/j.1365-2141.2007.06592.x
The paper
Panepinto, J. A., Walters, M. C., Carreras, J., Marsh, J., Bredeson, C. N., Gale, R. P., Hale, G. A., Horan, J., Hows, J. M., Klein, J. P., Pasquini, R., Roberts, I., Sullivan, K., Eapen, M., Ferster, A., & On behalf of the Non‐Malignant Marrow Disorders Working Committee, C. F. I. B. A. M. T. R. (2007). Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2007.06592.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.